{"id":404393,"date":"2019-07-02T11:00:01","date_gmt":"2019-07-02T11:00:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=404393"},"modified":"2019-07-02T11:00:01","modified_gmt":"2019-07-02T11:00:01","slug":"active-pharmaceutical-ingredient-api-market-registering-a-cagr-of-68-for-the-projected-period-from-2019-to-2026-grand-view-research-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/active-pharmaceutical-ingredient-api-market-registering-a-cagr-of-68-for-the-projected-period-from-2019-to-2026-grand-view-research-inc_404393.html","title":{"rendered":"Active Pharmaceutical Ingredient (API) Market Registering A CAGR Of 6.8% For The Projected Period From 2019 To 2026 : Grand View Research Inc."},"content":{"rendered":"
\"Active<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting.<\/div>\n<\/div>\n<\/div>\n
According to report published by Grand View Research, The global Active Pharmaceutical Ingredient (API) market size was valued at USD 158.15 billion in 2018 and is estimated to expand at a CAGR of 6.8% over the forecast years.<\/div>\n

The global active pharmaceutical ingredient (API) market<\/a><\/strong> size is expected to reach at USD 268.12 billion by 2026 registering a CAGR of 6.8%, according to a new report by Grand View Research, Inc. Rising trend of outsourcing APIs and growing prevalence of various target diseases, such as cancer, Cardiovascular Disease (CVDs) are anticipated to boost the market. Huge capital is required in API production as the process needs extremely systematic protocols. Pharmaceutical companies can actually benefit from outsourcing API production, as it eliminates the need for installing expensive manufacturing units. Moreover, strategic outsourcing enables companies to focus on their core competencies, ultimately resulting in increased productivity. These factors are also estimated to drive the demand in future.<\/p>\n

Growing geriatric population across the globe is also likely to contribute to the market expansion. Estimates published by the WHO suggest that the global base of population pertaining to the age group of 65 years and above is expected to rise from 7% in 2000 to 16% in 2050. Latin America, in particular, is projected to witness fastest growth, in terms of geriatric population, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%). Patent expiration of blockbuster drugs, growing outsourcing activities due to high manufacturing costs, and stringent regulations for API production are expected to intensify the market competition. As part of strategic geographic expansion, many companies are setting up manufacturing plants in the developing regions like Asia Pacific.<\/p>\n

\"U.S.<\/p>\n

Request a sample Copy of the<\/strong> Active Pharmaceutical Ingredient (API) Market<\/strong> Research Report @  <\/strong>https:\/\/www.grandviewresearch.com\/industry-analysis\/active-pharmaceutical-ingredients-market\/request\/rs1<\/a><\/strong><\/p>\n

Key Takeways Of The Report :<\/strong><\/p>\n